Patent: 5,480,640
✉ Email this page to a colleague
Summary for Patent: 5,480,640
Title: | Alpha interferon for treating prostate cancer |
Abstract: | Described is a method for treating carcinoma of the prostate using recombinant human alpha interferon via intraprostatic or intralesional injection. |
Inventor(s): | Morales; Alvaro (Kingston, CA), Wilson; James W. L. (Kingston, CA) |
Assignee: | Schering Corporation (Kenilworth, NJ) |
Application Number: | 08/432,742 |
Patent Claims: | see list of patent claims |
Details for Patent 5,480,640
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2039-03-29 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2039-03-29 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2039-03-29 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |